Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New clinical prediction tools for myeloma

Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.

CRUK Early Detection Primer Award for research into the clinical application of single cell genomics

Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.

High testosterone levels in men linked to increased melanoma risk

Research by Dr Eleanor Watts using UK Biobank data has uncovered this association for the first time

FDA clearance for Oxford spin-out’s early lung cancer diagnosis software

Optellum, an Oxford-based lung health company aiming to redefine early diagnosis and treatment of lung disease, has received FDA clearance for its AI-powered clinical decision support software.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.

Funding to improve childhood, teenage and young adult cancer detection

Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer

DeLIVER clinical research study underway

The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.

Early detection of sarcomas using liquid biopsy

Dr Felix Clanchy reviews the literature on the early detection of relapse for sarcomas associated with EWSR1 gene translocation

Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – registration open!

Join us for this free virtual event on 28-29th April 2021 to hear the latest developments from international leaders in these fields

Developing a system to simultaneously detect genetic and epigenetic information

Dr Benjamin Schuster-Böckler wins funding to develop algorithms that can identify both genetic variation and DNA methylation from the same sequencing data, with applications in biomedical research and detection of diseases such as cancer.

OxCODE researcher presents at CRUK Early Diagnosis series

Dr Brian Nicholson featured in the session on optimising the management of suspected cancer in primary care

Studying viral genetics to aid liver cancer early detection

Professor Ellie Barnes and Dr Azim Ansari receive funding to identify cancer-associated genotypes of hepatitis C in Pakistan to improve assessment of liver cancer risk.

Oxford paper is the British Journal of General Practice’s top publication of 2020

Research on the role of GPs’ gut feelings in diagnosing cancer in primary care was the journal’s most read paper last year.

Assessing the impact of the COVID-19 pandemic on bowel cancer services

Thousands of patients may have undiagnosed and untreated bowel cancer due to COVID-19 disruption.

Roadmap to the Future

Professor Fergus Gleeson participates in a panel discussion at this webinar launching the Early Detection and Diagnosis Roadmap.

Investigating the effects of co-morbidities on liver cancer risk

Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.

Potential of DNA-based blood tests for detecting pancreatic cancer earlier

Dr Shivan Sivakumar and colleagues evaluate the current progress and future potential in using genetic and epigenetic methods for detecting pancreatic cancer DNA in the blood.

Studying prostate cancer risk in the UK Biobank

Dr Eleanor Watts investigates the prostate cancer incidence and mortality risks associated with blood levels of insulin-like growth factor-1 and testosterone.

The impact of COVID-19 on breast cancer diagnoses

Dr Toral Gathani leads a study into the scale of the diagnostic delays in England.

Collating clinical data for liver disease research

The NIHR Health Informatics Collaborative Viral Hepatitis theme led by Professor Ellie Barnes has developed a pipeline to build a database of electronic clinical data that can support research into viral hepatitis and associated liver complications.

Load More